These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3344062)

  • 1. Plasma levels of heparin cofactor II in nephrotic syndrome of children.
    Sié P; Meguira B; Bouissou F; Boneu B; Barthe P
    Nephron; 1988; 48(2):175-6. PubMed ID: 3344062
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
    Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
    Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombin III and heparin cofactor II].
    Kondo S; Niwa M
    Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
    Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III (ATIII) and heparin cofactor II (HCII) in normal human fetuses (21st-27th week).
    Toulon P; Rainaut M; Aiach M; Roncato M; Daffos F; Forestier F
    Thromb Haemost; 1986 Oct; 56(2):237. PubMed ID: 3810560
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT).
    Tran TH; Duckert F
    Thromb Res; 1985 Nov; 40(4):571-6. PubMed ID: 3841235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1163-9. PubMed ID: 8264106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E; Oliver A; Félez J; Barceló P; Fernandez C; Ballarin JA; Fontcuberta J; Rutllant ML
    Thromb Haemost; 1988 Oct; 60(2):137-40. PubMed ID: 3217913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor II.
    Conard J; Bara L; Horellou MH; Samama MM
    Thromb Res; 1986 Mar; 41(6):873-8. PubMed ID: 3754659
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immuno turbidimetric assay of heparin cofactor II].
    Takahashi K; Yamagishi R; Sakuragawa N; Shimamoto M; Ohsawa T; Kita M
    Rinsho Byori; 1988 Aug; 36(8):947-51. PubMed ID: 3241422
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III, protein S, and coagulation in the nephrotic syndrome.
    Schnaper HW
    Pediatr Nephrol; 2001 Jan; 16(1):98. PubMed ID: 11198616
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of thrombophilia in nephrotic syndrome in children].
    Serebrianyĭ VL; Ignatova MS; Degtiareva EM; Svetlov SI
    Pediatriia; 1989; (1):49-53. PubMed ID: 2710603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microheterogeneity of plasma glycoproteins heparin cofactor II and antithrombin III and their carbohydrate analysis.
    Kim YS; Lee KB; Linhardt RJ
    Thromb Res; 1988 Jul; 51(1):97-104. PubMed ID: 3413738
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin cofactor II in adult glomerulopathy and nephrotic syndrome.
    Pech MA; Rostoker G; Soria C; Lang P; Weil B; Caen J; Lagrue G
    Am J Nephrol; 1991; 11(1):74-5. PubMed ID: 2048583
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels and loss of antithrombin III in chronic ambulatory peritoneal dialysis and nephrotic patients.
    Mori R; Triolo L; De Stefano V; Giusti BP; De Sole P; Leone G
    Nephron; 1988; 48(3):213-6. PubMed ID: 3352848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.